on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at MedInvest Biotech & Pharma Investor Conference
Jaguar Health, Inc. (NASDAQ:JAGX) announced that CEO Lisa Conte will present at the MedInvest Biotech & Pharma Investor Conference on September 19, 2024. The event will take place in New York City from September 18-19. Conte’s presentation is scheduled for 9:55 AM to 10:10 AM Eastern.
Jaguar Health is a commercial-stage pharmaceuticals company focused on developing proprietary medicines from rainforest plants. Its subsidiary, Napo Pharmaceuticals, concentrates on human prescription drugs for neglected gastrointestinal symptoms. The company’s FDA-approved drug, Mytesi®, provides relief for noninfectious diarrhea in HIV/AIDS patients on antiretroviral therapy.
Additionally, Jaguar's Napo Therapeutics aims to expand access to crofelemer in Europe, targeting orphan and rare diseases. Magdalena Biosciences, a joint venture with Filament Health Corp., focuses on mental health treatments derived from plants.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news